CancerSitala Bio identifies new complement factor B inhibitorsSitala Bio Ltd. has divulged complement factor B (CFB) inhibitors reported to be useful for the treatment of cancer, autoimmune and metabolic disease, eye, dermatological, respiratory, cardiovascular and renal disorders, among others.